Core Viewpoint - Rosen Law Firm is reminding investors of Molina Healthcare, Inc. about an important deadline related to a securities class action lawsuit, encouraging them to secure legal counsel before December 2, 2025 [2][4]. Group 1: Class Action Details - Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by December 2, 2025 [4][6]. - The lawsuit alleges that Molina failed to disclose critical information regarding its medical cost trends and financial guidance, which misled investors [6]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience [5]. - The Rosen Law Firm has a history of successful settlements and has recovered significant amounts for investors, including over $438 million in 2019 [5]. - The firm has been recognized for its performance in securities class action settlements, ranking highly in the industry [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Molina Healthcare, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions that affected the company's stock price [1][3]. Summary by Sections Class Action Details - The class period for the lawsuit is from February 5, 2025, to July 23, 2025 [3]. - Allegations include false statements about the company's medical cost trend assumptions and a dislocation between premium rates and medical costs [3]. - The lawsuit claims that Molina's near-term growth relied on reduced utilization of various health services, leading to a likely cut in financial guidance for fiscal year 2025 [3]. Shareholder Actions - Shareholders are encouraged to register for the class action by December 2, 2025, to potentially become lead plaintiffs [4]. - Registration allows shareholders to receive updates on the case through portfolio monitoring software [4]. Law Firm Background - The Gross Law Firm is recognized for its commitment to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies engage in responsible business practices and seeks recovery for investors affected by misleading statements [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Molina Healthcare, Inc. due to allegations of violations of federal securities laws related to misleading statements and undisclosed adverse facts affecting the company's financial performance [2][5]. Summary by Sections Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in Molina to contact them regarding their legal options, particularly for those who purchased securities between February 5, 2025, and July 23, 2025 [1][2]. Allegations Against Molina - The complaint alleges that Molina and its executives made false or misleading statements and failed to disclose critical information, including: - Material adverse facts about the company's medical cost trend assumptions [5]. - A dislocation between premium rates and medical costs [5]. - Dependency on low utilization of behavioral health, pharmacy, and inpatient and outpatient services for near-term growth [5]. - Likelihood of substantial cuts to financial guidance for fiscal year 2025 [5]. - Misleading positive statements regarding the company's business and prospects [5]. Financial Performance and Stock Impact - On July 7, 2025, Molina announced second-quarter financial results, revealing adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures, leading to a 10.2% cut in full-year earnings guidance from at least $24.50 to a range of $21.50 to $22.50 per share [6]. - Following this announcement, Molina's stock price fell by $6.97, or 2.9%, closing at $232.61 per share on July 7, 2025 [6]. - On July 23, 2025, Molina further slashed its full-year earnings guidance, reporting GAAP net income of $4.75 per diluted share for the second quarter, an 8% decrease year-over-year, and cutting full-year adjusted earnings guidance to no less than $19.00 per diluted share, representing a 13.6% reduction [7][8]. - This led to a significant drop in Molina's stock price by $32.03, or 16.84%, closing at $158.22 per share on July 24, 2025 [8].

Core Viewpoint - Rosen Law Firm is encouraging investors of Molina Healthcare, Inc. to secure legal counsel before the December 2, 2025 deadline for a class action lawsuit related to securities purchased between February 5, 2025, and July 23, 2025 [1] Group 1: Class Action Details - Investors who purchased Molina securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 2, 2025 [3] - The lawsuit alleges that Molina failed to disclose several material adverse facts regarding its financial health and operational assumptions, which misled investors [5] Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4] - The firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its success in securities class action settlements [4] Group 3: Case Specifics - The lawsuit claims that Molina's financial guidance for fiscal year 2025 was likely to be cut due to undisclosed issues related to medical cost trends and service utilization, which ultimately misled investors about the company's prospects [5]

Core Viewpoint - A class action securities lawsuit has been filed against Molina Healthcare, Inc. to recover losses incurred by shareholders due to alleged securities fraud between February 5, 2025, and July 23, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that the defendants made false statements and concealed material adverse facts regarding the company's medical cost trend assumptions [3]. - It is alleged that Molina was experiencing a dislocation between premium rates and medical cost trends, which was not disclosed [3]. - The complaint indicates that Molina's near-term growth relied on a lack of utilization of behavioral health, pharmacy, and inpatient and outpatient services [3]. - As a result of these issues, Molina's financial guidance for fiscal year 2025 was likely to be significantly reduced, and the positive statements made by the defendants about the company's business were misleading [3]. Group 2: Next Steps for Affected Shareholders - Shareholders who suffered losses during the specified timeframe are encouraged to learn about their rights to seek recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP is highlighted as a nationally recognized securities litigation firm with a strong track record in securing recoveries for shareholders [5]. - The firm has over 20 years of experience and has been consistently ranked among the top securities litigation firms in the United States [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Molina Healthcare, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Molina securities between February 5, 2025, and July 23, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 2, 2025 [3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering significant amounts for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Molina Healthcare failed to disclose several material adverse facts, including issues related to medical cost trend assumptions and the impact on financial guidance for fiscal year 2025 [5]. - Specific claims include a dislocation between premium rates and medical costs, reliance on limited service utilization for growth, and misleading positive statements about the company's business prospects [5].

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the "Company†) today announced that it priced $850 million aggregate principal amount of its 6.500% senior notes due 2031 (the "Notes†) to be sold in a private offering to individuals reasonably believed to be "qualified institutional buyers†pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act†), and to certain non-U.S. persons outside the United States in reliance on Regulation S under. ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Molina Healthcare, Inc. securities between February 5, 2025, and July 23, 2025, of the December 2, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Molina securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by December 2, 2025, to serve as lead plaintiff [2] - The lawsuit alleges that Molina failed to disclose several material adverse facts regarding its financial health and operational assumptions, which misled investors [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time and has been ranked highly for its performance in securities class action settlements [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3]

Core Viewpoint - Molina Healthcare, Inc. plans to privately offer $750 million in senior notes due 2031, subject to market conditions [1] Group 1: Offering Details - The offering will consist of an aggregate principal amount of $750 million [1] - The notes will be due in 2031 [1] - The offering will be made under an exemption from the Securities Act of 1933 [1] Group 2: Target Investors - The initial purchasers will offer the notes only to persons reasonably believed to be "qualified institutional buyers" [1]

Core Viewpoint - Rosen Law Firm is reminding investors of Molina Healthcare, Inc. about an important deadline related to a securities class action lawsuit, encouraging them to secure legal counsel before December 2, 2025 [1][3]. Group 1: Class Action Details - Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by December 2, 2025 [3]. - The lawsuit alleges that Molina failed to disclose several material adverse facts regarding its financial health and operational assumptions, which misled investors [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of successful settlements in securities class actions, having recovered hundreds of millions of dollars for investors [4]. Group 3: Case Specifics - The lawsuit claims that Molina's financial guidance for fiscal year 2025 was likely to be cut due to undisclosed issues related to medical cost trends and service utilization [5]. - The misleading statements made by Molina regarding its business operations and prospects are central to the claims made in the lawsuit [5].